Teva- Pharmaceutical Industries Ltd
TEVAHealthcare·Drug Manufacturers - Specialty & Generic·Israel·Large·NYSE·Nov 11 • 3:59 PM ET
Price
TEVA against its 20, 50 and 200-day averages0.2% under the 52-week high of 43.34 on 3 Nov 2026. 52-week low 24.01 on 21 Nov 2025. Last 15 sessions, 10.8% high to low
Volume 1.63× normal · the line is the 50-bar volume average
Profile
TEVATeva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
| Employees | 33346 |
|---|---|
| IPO | Feb 16, 1982 |
| Beta | 0.98 |
| ATR, 14d | 1.23 |
| Rel volume | 1.63 |
| Short float | 2.50% |
| Insider own | 4.90% |
| Inst own | 50.49% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 50.45B |
| Enterprise Value | 63.36B |
| Income | 506.00M |
| Sales | 17.24B |
| Book/sh | 6.84 |
| Cash/sh | 3.50 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | Nov 27, 2017 |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 33346 |
| IPO | Feb 16, 1982 |
Ratios
| P/E | 101.81 |
|---|---|
| Forward P/E | 13.87 |
| PEG | 2.29 |
| P/S | 2.93 |
| P/B | 6.32 |
| P/C | 12.35 |
| P/FCF | 19.35 |
| EV/EBITDA | 14.75 |
| EV/Sales | 3.68 |
| Quick Ratio | 0.74 |
| Current Ratio | 0.95 |
| Debt/Eq | 2.13 |
| LT Debt/Eq | 1.62 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 0.42 |
|---|---|
| EPS next Y | 3.12 |
| EPS next Q | 0.66 |
| EPS this Y | -29.80% |
| EPS next Y | 51.53% |
| EPS next 5Y | 6.07% |
| EPS past 3/5Y | - - |
| Sales past 3/5Y | 5.12% 0.78% |
| EPS Y/Y TTM | -28.63% |
| Sales Y/Y TTM | 2.99% |
| EPS Q/Q | -47.04% |
| Sales Q/Q | -2.24% |
| Earnings | Nov 03 BMO |
| EPS/Sales Surpr. | 19.31% 3.85% |
Ownership
| Insider Own | 4.90% |
|---|---|
| Insider Trans | -1.46% |
| Inst Own | 50.49% |
| Inst Trans | 8.62% |
| ROA | 1.27% |
| ROE | 6.65% |
| ROIC | 2.42% |
| Gross Margin | 53.53% |
| Oper. Margin | 19.21% |
| Profit Margin | 2.94% |
| SMA20 | 4.65% |
| SMA50 | 8.36% |
| SMA200 | 23.80% |
| Trades | - |
Technical
| Shs Outstand | 1.17B |
|---|---|
| Shs Float | 1.11B |
| Short Float | 2.50% |
| Short Ratio | 4.73 |
| Short Interest | 27.74M |
| 52W High | 43.34 -0.23% |
| 52W Low | 24.01 80.09% |
| Volatility | 2.45% 2.71% |
| ATR (14) | 1.23 |
| RSI (14) | 63.87 |
| Beta | 0.98 |
| Rel Volume | 1.63 |
| Avg Volume | 5.87M |
| Volume | 9,562,603 |
Performance
| Perf Week | 3.32% |
|---|---|
| Perf Month | 4.82% |
| Perf Quarter | 18.40% |
| Perf Half Y | 19.28% |
| Perf YTD | 38.55% |
| Perf Year | 72.07% |
| Perf 3Y | 398.76% |
| Perf 5Y | 353.25% |
| Perf 10Y | 6.37% |
| Recom | 1.31 |
| Target Price | 51.42 |
| Prev Close | 42.40 |
| Price | 43.24 |
| Change % | 1.98% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Nov 02, 2026 | Initiated | HH.C. Wainwright | Buy | $52 | +20.3% |
| Oct 01, 2026 | Initiated | TTD Cowen | Buy | $55 | +27.2% |
| Sep 23, 2026 | Initiated | OOppenheimer | Outperform | $50 | +15.6% |
| Sep 09, 2026 | Initiated | LLeerink Partners | Outperform | $45 | +4.1% |
| Dec 09, 2025 | Initiated | BBarclays | Overweight | $35 | -19.1% |
| Dec 05, 2025 | Initiated | BScotiabank | Sector Outperform | $35 | -19.1% |
| Jun 06, 2025 | Initiated | GGoldman | Buy | $24 | -44.5% |
| May 28, 2025 | Initiated | TTruist | Buy | $25 | -42.2% |
| May 12, 2025 | Upgrade | JJP Morgan | Neutral → Overweight | $23 | -46.8% |
| Jul 10, 2024 | Upgrade | AArgus | Hold → Buy | $20 | -53.7% |
Peers
Mkt capInsider trading
latest 14 of 94| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Francis Richard D. | Officer | Nov 10 '26 | Proposed Sale | 42.97 | 250,000 | 10,742,500 | Nov 10 04:16 PM | |
| Daniell Richard | Officer | Nov 09 '26 | Proposed Sale | 42.91 | 25,000 | 1,072,789 | Nov 09 04:03 PM | |
| Sabag Mark | See "Remarks" | Nov 05 '26 | Option Exercise | 34.90 | 46,000 | 1,605,400 | 126,760 | Nov 06 04:03 PM |
| Sabag Mark | See "Remarks" | Nov 05 '26 | Sale | 41.93 | 46,000 | 1,928,729 | 80,760 | Nov 06 04:03 PM |
| Bergwerk Dov | Interim Cheif Legal Officer | Nov 04 '26 | Option Exercise | 32.79 | 26,260 | 861,143 | 29,448 | Nov 06 04:01 PM |
| Bergwerk Dov | Interim Cheif Legal Officer | Nov 04 '26 | Sale | 41.72 | 26,260 | 1,095,567 | 11,943 | Nov 06 04:01 PM |
| Sabag Mark | Officer | Nov 05 '26 | Proposed Sale | 41.93 | 46,000 | 1,928,728 | Nov 05 04:00 PM | |
| Bergwerk Dov | Senior VP General Counsel Corp | Nov 04 '26 | Proposed Sale | 41.72 | 26,260 | 1,095,567 | Nov 04 04:00 PM | |
| Savage Brian | Interim Chief Legal Officer | Sep 18 '26 | Option Exercise | 34.70 | 4,503 | 156,254 | 15,842 | Sep 22 05:01 PM |
| Savage Brian | Interim Chief Legal Officer | Sep 18 '26 | Sale | 38.85 | 7,342 | 285,215 | 8,500 | Sep 22 05:01 PM |
| MIGNONE ROBERTO | Director | Sep 18 '26 | Sale | 39.06 | 367,600 | 14,356,802 | 0 | Sep 22 04:21 PM |
| Savage Brian | Officer | Sep 18 '26 | Proposed Sale | 38.85 | 7,028 | 273,062 | Sep 21 06:40 AM | |
| Bridger Management, LLC (1) | Shareholder | Sep 18 '26 | Proposed Sale | 39.19 | 367,600 | 14,406,244 | Sep 18 05:00 PM | |
| Weiss Amir | Chief Accounting Officer | Aug 21 '26 | Option Exercise | 19.61 | 2,500 | 49,025 | 15,571 | Aug 25 04:05 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IEFA | iShares Core MSCI EAFE ETF | AUM: 191.66B |
| EFA | iShares MSCI EAFE ETF | AUM: 77.26B |
| EIS | iShares MSCI Israel ETF | AUM: 830.45M |
| EFG | iShares MSCI EAFE Growth ETF | AUM: 15.14B |
| IXUS | iShares Core MSCI Total International Stock ETF | AUM: 57.59B |
| IDEV | iShares Core MSCI International Developed Markets ETF | AUM: 34.12B |
| SPDW | State Street SPDR Portfolio Developed World ex-US ETF | AUM: 41.64B |
| WCMI | First Trust WCM International Equity ETF | AUM: 2.12B |
| PPH | VanEck Pharmaceutical ETF | AUM: 1.09B |
| FNDF | Schwab Fundamental International Equity ETF | AUM: 25.65B |
News
latest 14 of 200- Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6-7 Billion in Innovative Medicines Revenue by 2030 (GlobeNewswire)
- FDA Decision Watch: Summits Lung Cancer Drug, Cytokinetics Heart Therapy And Tevas Igalmi In Spotlight This Week (Stocktwits)
- Teva Beats On Margin And Brand Strength, But Shrinking Sales And A 2027 AUSTEDO Pricing Reset Keep Bears In The Game (Earnings Whispers)
- Teva Leans On A Key Trio To Beat Third-Quarter Forecasts; Shares Hit Buy Zone (Investor's Business Daily)
- UniQure gets an FDA decision date; Teva scraps brain drug study (BioPharma Dive)
- Teva's Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO, AJOVY and UZEDY; Delivers Substantial Gross Margin Expansion (GlobeNewswire)
- Medincell - UZEDY: Q3 U.S. Net Sales Reach $85M, Up 96% Year-on-Year; 2026 Revenue Outlook Raised to $290-310M (Business Wire)
- Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S. (GlobeNewswire)
- Teva shares slide after drug trial discontinuation (Investing.com)
- Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-'286) Following Interim Futility Analysis (GlobeNewswire)
- Stocktwits Biotech Dealmaker: BioMarins Fabry Disease Drug Candidate License Dominates Slow Week In Dealmaking (Stocktwits)
- Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline (GlobeNewswire)
- Teva's Austedo-Led Turnaround Faces A Margin Test As Generics Drag On Third-Quarter Results (Earnings Whispers)
- Sanofi & Tevas IBD drug prompts long-term clinical remission in Phase IIb trial (Clinical Trials Arena)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-03 | 0.860 | 0.721 | 0.200 | 4,395 | 4,232 | 12 |
| 2026Q2 | 2026-07-29 | 0.020 | 0.052 | -0.494 | 4,142 | 4,021 | 8 |
| 2026Q1 | 2026-04-29 | 0.530 | 0.471 | 0.313 | 3,982 | 3,787 | 9 |
| 2025Q4 | 2026-01-28 | 0.960 | 0.641 | 0.409 | 4,711 | 4,317 | 8 |
| 2025Q3 | 2025-11-05 | 0.780 | 0.690 | 0.372 | 4,480 | 4,356 | 6 |
| 2025Q2 | 2025-07-30 | 0.660 | 0.617 | 0.243 | 4,176 | 4,272 | 6 |
| 2025Q1 | 2025-05-07 | 0.520 | 0.463 | 0.185 | 3,891 | 3,988 | 4 |
| 2024Q4 | 2025-01-29 | 0.710 | 0.707 | -0.192 | 4,229 | 4,146 | 5 |
| 2024Q3 | 2024-11-06 | 0.690 | 0.661 | -0.386 | 4,332 | 4,140 | 5 |
| 2024Q2 | 2024-07-31 | 0.610 | 0.552 | -0.747 | 4,164 | 4,055 | 5 |
| 2024Q1 | 2024-05-08 | 0.480 | 0.514 | -0.124 | 3,819 | 3,732 | 7 |
| 2023Q4 | 2024-01-31 | 1.000 | 0.768 | 0.406 | 4,457 | 4,027 | 8 |
| 2023Q3 | 2023-11-08 | 0.600 | 0.608 | 0.071 | 3,850 | 3,733 | 8 |
| 2023Q2 | 2023-08-02 | 0.560 | 0.525 | -0.771 | 3,878 | 3,714 | 7 |
| 2023Q1 | 2023-05-10 | 0.400 | 0.557 | -0.184 | 3,661 | 3,620 | 8 |
| 2022Q4 | 2023-02-08 | 0.710 | 0.715 | -1.099 | 3,884 | 3,888 | 10 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 2.400 | 2.380 | -0.916 | 16,887 | 17,252 |
| 2020FY | 2.570 | 2.507 | -3.644 | 16,659 | 16,594 |
| 2021FY | 2.580 | 2.540 | 0.377 | 15,878 | 16,068 |
| 2022FY | 2.520 | 2.522 | -2.204 | 14,925 | 14,952 |
| 2023FY | 2.560 | 2.317 | -0.500 | 15,846 | 15,385 |
| 2024FY | 2.490 | 2.478 | -1.449 | 16,544 | 16,445 |
| 2025FY | 2.930 | 2.630 | 1.230 | 17,258 | 16,893 |
| 2026FY | - | 2.057 | - | - | 16,785 |
| 2027FY | - | 3.117 | - | - | 17,358 |
| 2028FY | - | 3.497 | - | - | 18,163 |
| 2029FY | - | 3.762 | - | - | 18,775 |
| 2030FY | - | 4.127 | - | - | 19,570 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-11 | 11 | 4 | 1 | 4,266 | 4,159 | 4,356 |
| 2026Q4 | S | 2026-11-10 | 11 | 4 | 1 | 4,266 | 4,159 | 4,356 |
| 2026Q4 | S | 2026-11-03 | 11 | 3 | 1 | 4,255 | 4,159 | 4,356 |
| 2026Q4 | S | 2026-10-30 | 11 | 1 | 0 | 4,240 | 4,080 | 4,495 |
| 2026Q4 | S | 2026-10-21 | 10 | 1 | 0 | 4,214 | 4,080 | 4,353 |
| 2026Q4 | S | 2026-10-12 | 10 | 1 | 0 | 4,212 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-10-09 | 10 | 1 | 4 | 4,212 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-10-08 | 10 | 1 | 4 | 4,216 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-30 | 10 | 1 | 4 | 4,216 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-29 | 9 | 1 | 4 | 4,211 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-22 | 9 | 1 | 4 | 4,211 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-08 | 8 | 1 | 4 | 4,213 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-03 | 7 | 1 | 4 | 4,208 | 4,080 | 4,335 |
| 2026Q4 | S | 2026-09-01 | 7 | 1 | 4 | 4,211 | 4,080 | 4,335 |
Estimate history
| EPS, annual | -16.265 | -2.35 | -0.916 | -3.644 | 0.377 | -2.204 | -0.5 | -1.449 | 1.212 | 0.4247 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | -0.386 | -0.192 | 0.185 | 0.243 | 0.372 | 0.409 | 0.313 | -0.494 | 0.197 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 22385 | 18271 | 16873 | 16659 | 15847 | 14914 | 15848 | 16510 | 17323 | 17239 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 4341 | 4196 | 3864 | 4208 | 4471 | 4725 | 3993 | 4150 | 4371 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 1017 | 1090 | 1092 | 1096 | 1103.33 | 1111 | 1121.094 | 1133 | 1150 | 1167 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 1134 | 1133 | 1147 | 1147 | 1147 | 1150 | 1164 | 1165 | 1167 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17,239.00 | 17,323.00 | 16,510.00 | 15,848.00 | 14,914.00 | 15,847.00 | 16,659.00 | 16,873.00 | 18,271.00 |
| Cost of Goods Sold Incl. D&A | 8,011.00 | 8,320.00 | 8,481.00 | 8,200.00 | 7,952.00 | 8,383.00 | 8,933.00 | 9,351.00 | 9,975.00 |
| Gross Profit | 9,228.00 | 9,003.00 | 8,029.00 | 7,648.00 | 6,962.00 | 7,464.00 | 7,726.00 | 7,522.00 | 8,296.00 |
| Selling, General and Administrative Excl. Other | 5,917.00 | 4,986.00 | 4,700.00 | 4,451.00 | 4,283.00 | 4,396.00 | 4,668.00 | 4,816.00 | 5,427.00 |
| Research and Development | 1,756.00 | 1,013.00 | 998.00 | 953.00 | 838.00 | 967.00 | 997.00 | 1,010.00 | 1,213.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | - | 0.00 | - | 0.00 | 0.00 | 0.00 |
| Operating Income | 3,311.00 | 4,017.00 | 3,329.00 | 3,197.00 | 2,679.00 | 3,068.00 | 3,058.00 | 2,706.00 | 2,869.00 |
| Interest Expense | 1,115.00 | 941.00 | 941.00 | 1,041.00 | 981.00 | 1,006.00 | 755.00 | 957.00 | 940.00 |
| Unusual Expense | 1,932.00 | 1,883.00 | 3,767.00 | 2,831.00 | 4,924.00 | 1,346.00 | 6,773.00 | 3,115.00 | 4,718.00 |
| Net Income Before Taxes | 362.00 | 1,223.00 | -1,284.00 | -624.00 | -3,163.00 | 658.00 | -4,406.00 | -1,265.00 | -2,596.00 |
| Income Taxes | -135.00 | -180.00 | 676.00 | -7.00 | -643.00 | 211.00 | -168.00 | -278.00 | -195.00 |
| Consolidated Net Income | 507.00 | 1,418.00 | -1,959.00 | -615.00 | -2,499.00 | 456.00 | -4,100.00 | -1,000.00 | -2,472.00 |
| Net Income From Continuing Operations | 506.00 | 1,410.00 | -1,639.00 | -559.00 | -2,446.00 | 417.00 | -3,990.00 | -999.00 | -2,150.00 |
| Net Income | 506.00 | 1,410.00 | -1,639.00 | -559.00 | -2,446.00 | 417.00 | -3,990.00 | -999.00 | -2,399.00 |
| EPS (Recurring) | 1.57 | 2.35 | 0.88 | 1.27 | 0.90 | 1.23 | 0.69 | 1.08 | 0.89 |
| EPS (Basic, Before Extraordinaries) | 0.44 | 1.23 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.92 | -2.35 |
| EPS (Diluted) | 0.42 | 1.21 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.92 | -2.35 |
| EBITDA | 4,296.00 | 5,019.00 | 4,388.00 | 4,350.00 | 3,987.00 | 4,398.00 | 4,615.00 | 4,428.00 | 4,711.00 |
| Non-Operating Income (Expense) | 97.00 | 30.00 | 95.00 | 51.00 | 63.00 | -58.00 | 64.00 | 101.00 | 193.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 132.44 | 143.00 | 112.00 | 110.00 | 115.00 | 91.63 | 99.33 | 105.00 | 137.00 |
| Price To Earnings Ratio | 101.81 | 101.81 | - | - | - | 21.17 | - | - | - |
| Price To Sales Ratio | 2.75 | 2.13 | 1.52 | 0.75 | 0.70 | 0.60 | 0.63 | 0.64 | 0.88 |
| Gross Margin | 53.53 | 51.97 | 48.63 | 48.26 | 46.68 | 47.10 | 46.38 | 44.58 | 45.41 |
| Operating Margin | 19.21 | 23.19 | 20.16 | 20.17 | 17.96 | 19.36 | 18.36 | 16.04 | 15.70 |
| Net Margin | 2.94 | 8.14 | -9.93 | -3.53 | -16.40 | 2.63 | -23.95 | -5.92 | -13.13 |
| Shares Outstanding | 1,167.00 | 1,150.00 | 1,133.00 | 1,121.09 | 1,111.00 | 1,103.33 | 1,096.00 | 1,092.00 | 1,090.00 |
| Market Capitalization | 50,453.73 | 50,453.73 | 25,006.36 | 11,701.88 | 10,128.22 | 8,835.11 | 10,576.11 | 10,702.48 | 15,708.82 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,371.00 | 4,150.00 | 3,993.00 | 4,725.00 | 4,471.00 | 4,208.00 | 3,864.00 | 4,196.00 |
| Cost of Goods Sold Incl. D&A | 1,955.00 | 1,989.00 | 2,011.00 | 2,056.00 | 2,176.00 | 2,074.00 | 2,014.00 | 2,109.00 |
| Gross Profit | 2,416.00 | 2,161.00 | 1,982.00 | 2,669.00 | 2,295.00 | 2,134.00 | 1,850.00 | 2,087.00 |
| Selling, General and Administrative Excl. Other | 1,304.00 | 2,004.00 | 1,222.00 | 1,387.00 | 1,229.00 | 1,203.00 | 1,166.00 | 1,200.00 |
| Research and Development | 297.00 | 970.00 | 222.00 | 267.00 | 256.00 | 244.00 | 247.00 | 248.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 1,112.00 | 157.00 | 760.00 | 1,282.00 | 1,066.00 | 931.00 | 684.00 | 887.00 |
| Interest Expense | 420.00 | 264.00 | 215.00 | 216.00 | 237.00 | 283.00 | 287.00 | 142.00 |
| Unusual Expense | 460.00 | 366.00 | 123.00 | 983.00 | 175.00 | 440.00 | 99.00 | 982.00 |
| Net Income Before Taxes | 300.00 | -455.00 | 437.00 | 80.00 | 646.00 | 203.00 | 294.00 | -247.00 |
| Income Taxes | 66.00 | 121.00 | 67.00 | -389.00 | 214.00 | -78.00 | 74.00 | 29.00 |
| Consolidated Net Income | 234.00 | -576.00 | 369.00 | 480.00 | 434.00 | 282.00 | 220.00 | -275.00 |
| Net Income From Continuing Operations | 233.00 | -576.00 | 369.00 | 480.00 | 433.00 | 282.00 | 214.00 | -217.00 |
| Net Income | 233.00 | -576.00 | 369.00 | 480.00 | 433.00 | 282.00 | 214.00 | -217.00 |
| EPS (Recurring) | 0.47 | -0.27 | 0.39 | 1.00 | 0.48 | 0.51 | 0.24 | 0.42 |
| EPS (Basic, Before Extraordinaries) | 0.20 | -0.49 | 0.32 | 0.42 | 0.38 | 0.25 | 0.19 | -0.19 |
| EPS (Diluted) | 0.20 | -0.49 | 0.31 | 0.41 | 0.37 | 0.24 | 0.18 | -0.19 |
| EBITDA | 1,357.00 | 398.00 | 999.00 | 1,542.00 | 1,315.00 | 1,182.00 | 928.00 | 1,156.00 |
| Non-Operating Income (Expense) | 68.00 | 18.00 | 14.00 | -3.00 | -9.00 | -5.00 | -3.00 | -10.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 29.26 | 30.80 | 33.11 | 39.27 | 26.18 | 29.26 | 26.18 | 26.86 |
| Price To Earnings Ratio | 101.81 | 25.18 | 24.74 | 50.97 | - | - | - | - |
| Price To Sales Ratio | 2.75 | 2.22 | 1.98 | 2.15 | 1.36 | 1.18 | 1.05 | 1.52 |
| Gross Margin | 55.27 | 52.07 | 49.64 | 56.49 | 51.33 | 50.71 | 47.88 | 49.74 |
| Operating Margin | 25.44 | 3.78 | 19.03 | 27.13 | 23.84 | 22.12 | 17.70 | 21.14 |
| Net Margin | 5.33 | -13.88 | 9.24 | 10.16 | 9.68 | 6.70 | 5.54 | -5.17 |
| Shares Outstanding | 1,167.00 | 1,165.00 | 1,164.00 | 1,150.00 | 1,147.00 | 1,147.00 | 1,147.00 | 1,133.00 |
| Market Capitalization | 50,453.73 | 39,458.00 | 35,078.96 | 35,792.88 | 23,166.17 | 19,221.04 | 17,611.56 | 25,006.36 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 3,556.00 | 3,300.00 | 3,226.00 | 2,801.00 | 2,165.00 | 2,177.00 | 1,975.00 | 1,782.00 | 980.00 |
| Short Term Receivables | 3,708.00 | 3,059.00 | 3,408.00 | 3,696.00 | 4,529.00 | 4,581.00 | 5,676.00 | 5,822.00 | 7,128.00 |
| Inventories | 3,179.00 | 3,007.00 | 4,022.00 | 3,833.00 | 3,818.00 | 4,403.00 | 4,422.00 | 4,731.00 | 4,924.00 |
| Other Current Assets | 3,503.00 | 3,186.00 | 1,829.00 | 1,721.00 | 2,060.00 | 1,844.00 | 1,391.00 | 1,459.00 | 2,350.00 |
| Total Current Assets | 13,946.00 | 12,552.00 | 12,485.00 | 12,051.00 | 12,572.00 | 13,005.00 | 13,464.00 | 13,794.00 | 15,382.00 |
| Net Property, Plant & Equipment | 4,425.00 | 4,948.00 | 6,147.00 | 6,158.00 | 6,477.00 | 6,855.00 | 6,950.00 | 6,868.00 | 7,673.00 |
| Total Investments and Advances | 0.00 | 0.00 | 8.00 | 0.00 | 0.00 | 0.00 | 0.00 | 58.00 | 25.00 |
| Intangible Assets | 19,781.00 | 19,565.00 | 22,564.00 | 23,903.00 | 27,506.00 | 29,547.00 | 36,078.00 | 38,922.00 | 46,054.00 |
| Deferred Tax Assets | 2,191.00 | 1,799.00 | 1,812.00 | 1,458.00 | 596.00 | 695.00 | 386.00 | 368.00 | 574.00 |
| Other Assets | 405.00 | 462.00 | 463.00 | 441.00 | 515.00 | 538.00 | 592.00 | 673.00 | 907.00 |
| Total Assets | 40,748.00 | 39,326.00 | 43,479.00 | 44,011.00 | 47,666.00 | 50,640.00 | 57,470.00 | 60,683.00 | 70,615.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 1,915.00 | 1,868.00 | 1,769.00 | 2,202.00 | 1,535.00 | 3,304.00 | 2,463.00 | 2,216.00 | 3,646.00 |
| Accounts Payable | 2,531.00 | 2,203.00 | 2,602.00 | 1,887.00 | 1,686.00 | 1,756.00 | 1,718.00 | 1,853.00 | 2,069.00 |
| Other Current Liabilities | 9,010.00 | 8,725.00 | 7,876.00 | 7,379.00 | 7,806.00 | 8,104.00 | 9,493.00 | 10,253.00 | 12,206.00 |
| Total Current Liabilities | 13,456.00 | 12,796.00 | 12,247.00 | 11,468.00 | 11,027.00 | 13,164.00 | 13,674.00 | 14,322.00 | 17,921.00 |
| Long Term Debt | 15,311.00 | 16,316.00 | 18,504.00 | 19,452.00 | 22,033.00 | 23,210.00 | 24,997.00 | 26,700.00 | 28,829.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 296.00 | 483.00 | 606.00 | 548.00 | 784.00 | 964.00 | 1,096.00 | 2,140.00 | 3,277.00 |
| Other Liabilities | 3,771.00 | 4,011.00 | 3,996.00 | 3,945.00 | 2,578.00 | 2,241.00 | 2,640.00 | 1,727.00 | 1,843.00 |
| Total Liabilities | 32,834.00 | 33,606.00 | 35,353.00 | 35,413.00 | 36,422.00 | 39,579.00 | 42,407.00 | 44,889.00 | 51,870.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,631.00 |
| Common Equity | 7,910.00 | 5,373.00 | 7,506.00 | 7,804.00 | 10,278.00 | 10,026.00 | 13,972.00 | 14,707.00 | 13,728.00 |
| Total Shareholders Equity | 7,910.00 | 5,373.00 | 7,506.00 | 7,804.00 | 10,278.00 | 10,026.00 | 13,972.00 | 14,707.00 | 17,359.00 |
| Accumulated Minority Interest | 4.00 | 347.00 | 620.00 | 794.00 | 966.00 | 1,035.00 | 1,091.00 | 1,087.00 | 1,386.00 |
| Total Equity | 7,914.00 | 5,720.00 | 8,126.00 | 8,598.00 | 11,244.00 | 11,061.00 | 15,063.00 | 15,794.00 | 18,745.00 |
| Total Liabilities & Stockholders Equity | 40,748.00 | 39,326.00 | 43,479.00 | 44,011.00 | 47,666.00 | 50,640.00 | 57,470.00 | 60,683.00 | 70,615.00 |
| Book Value Per Share | 6.88 | 4.74 | 6.70 | 7.02 | 9.32 | 9.15 | 12.79 | 13.49 | 13.50 |
| Tangible Book Value Per Share | -10.32 | -12.53 | -13.43 | -14.49 | -15.61 | -17.81 | -20.24 | -22.22 | -31.79 |
| Full-Time Employees | 33,346 | 36,167 | 37,226 | 36,826 | 37,537 | 39,717 | 40,039 | 42,535 | 51,792 |
| Price to Book Ratio | 6.32 | 4.12 | 1.69 | 1.16 | 0.86 | 1.05 | 0.77 | 1.14 | 0.77 |
| Return on Assets | 3.52 | -3.96 | -1.28 | -5.34 | 0.85 | -7.38 | -1.69 | -3.27 | -19.88 |
| Return on Equity | 21.23 | -25.45 | -7.26 | -27.05 | 4.11 | -33.25 | -6.97 | -13.41 | -64.17 |
| Return on Invested Capital | 6.07 | -7.56 | -2.15 | -8.97 | 1.29 | -12.01 | -2.56 | -5.19 | -35.21 |
| Quick Ratio | 0.80 | 0.75 | 0.69 | 0.72 | 0.79 | 0.65 | 0.66 | 0.63 | 0.58 |
| Current Ratio | 1.04 | 0.98 | 1.02 | 1.05 | 1.14 | 0.99 | 0.98 | 0.96 | 0.86 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 551.29 | 1,418.00 | -1,959.00 | -615.00 | -2,499.00 | 456.00 | -4,099.00 | -1,001.00 | -2,472.00 |
| Depreciation | 1,014.49 | 1,002.00 | 1,059.00 | 1,153.00 | 1,308.00 | 1,330.00 | 1,557.00 | 1,722.00 | 1,842.00 |
| Other Funds (Non Cash) | 3,478.10 | 2,480.00 | 4,507.00 | 2,696.00 | 3,630.00 | 2,481.00 | 8,047.00 | 3,367.00 | 7,606.00 |
| Funds from Operations | 4,467.87 | 4,229.00 | 2,973.00 | 2,917.00 | 1,375.00 | 4,147.00 | 4,809.00 | 3,103.00 | 6,139.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -1,309.51 | -1,366.00 | -435.00 | -72.00 | 1,355.00 | -1,701.00 | -2,188.00 | -868.00 | -1,958.00 |
| Cash from Operating Activities | 3,158.37 | 2,863.00 | 2,538.00 | 2,845.00 | 2,730.00 | 2,446.00 | 2,621.00 | 2,235.00 | 4,181.00 |
| Capital Expenditures | -550.40 | -501.00 | -498.00 | -526.00 | -548.00 | -562.00 | -578.00 | -525.00 | -651.00 |
| Net Assets From Acquisitions | -0.57 | -38.00 | -79.00 | 0.00 | -7.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00 | 890.00 |
| Purchase or Sale of Investments | -663.32 | 42.00 | 40.00 | 0.00 | 4.00 | 172.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -707.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
| Sale Or Maturity of Investments | 44.55 | 42.00 | 40.00 | 0.00 | 4.00 | 172.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | -60.45 | -57.00 | -71.00 | -51.00 | -1.00 | -47.00 | -55.00 | -8.00 | -119.00 |
| Other Sources | 96.93 | 39.00 | 45.00 | 68.00 | 68.00 | 312.00 | 91.00 | 58.00 | 11.00 |
| Cash from Investing Activities | -1,177.82 | -515.00 | -563.00 | -509.00 | -484.00 | -125.00 | -542.00 | -132.00 | 131.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -52.00 | -22.00 |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -88.40 | -1,814.00 | -1,641.00 | -1,701.00 | -1,369.00 | -2,166.00 | -1,880.00 | -1,863.00 | -3,272.00 |
| Change in Long Term Debt | -88.40 | -1,814.00 | -1,641.00 | -1,701.00 | -1,369.00 | -1,675.00 | -1,871.00 | -1,861.00 | -3,012.00 |
| Issuance of Long Term Debt | 4,896.89 | 2,298.00 | 0.00 | 2,451.00 | 0.00 | 4,974.00 | 0.00 | 2,083.00 | 4,434.00 |
| Reduction of Long Term Debt | -4,985.29 | -4,112.00 | -1,641.00 | -4,152.00 | -1,369.00 | -6,649.00 | -1,871.00 | -3,944.00 | -7,446.00 |
| Net Financing Active Other Cash Flow | 115.63 | -299.00 | -86.00 | -212.00 | -118.00 | -6.00 | -5.00 | -11.00 | -57.00 |
| Other Financing Activities Uses | -5.09 | -340.00 | -86.00 | -212.00 | -118.00 | -6.00 | -5.00 | -11.00 | -57.00 |
| Cash from Financing Activities | 28.23 | -2,113.00 | -1,727.00 | -1,913.00 | -1,487.00 | -2,172.00 | -1,885.00 | -1,926.00 | -3,351.00 |
| Exchange Rate Effect | -59.32 | 21.00 | -174.00 | -30.00 | -123.00 | -128.00 | 8.00 | 16.00 | -142.00 |
| Net Change in Cash | 1,949.46 | 256.00 | 74.00 | 393.00 | 636.00 | 21.00 | 202.00 | 193.00 | 819.00 |
| Free Cash Flow | 2,607.97 | 2,362.00 | 2,040.00 | 2,319.00 | 2,182.00 | 1,884.00 | 2,043.00 | 1,710.00 | 3,530.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -52.00 | -10.00 |
| Price to Free Cash Flow | 18.16 | 15.59 | 12.33 | 5.15 | 4.76 | 5.09 | 5.10 | 6.52 | 4.57 |
| Deferred Taxes & Investment Tax Credit | - | -671.00 | -634.00 | -317.00 | -1,064.00 | -120.00 | -696.00 | -985.00 | -837.00 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4,085.00 | 3,655.00 | 3,741.00 | 3,556.00 | 2,203.00 | 2,161.00 |
| Short Term Receivables | 3,837.00 | 3,493.00 | 3,393.00 | 3,708.00 | 3,810.00 | 3,564.00 |
| Inventories | 3,173.00 | 3,221.00 | 3,176.00 | 3,179.00 | 3,323.00 | 3,497.00 |
| Other Current Assets | 3,508.00 | 3,391.00 | 3,399.00 | 3,503.00 | 3,401.00 | 3,398.00 |
| Total Current Assets | 14,602.00 | 13,760.00 | 13,710.00 | 13,946.00 | 12,736.00 | 12,620.00 |
| Net Property, Plant & Equipment | 4,068.00 | 4,261.00 | 4,333.00 | 4,425.00 | 5,162.00 | 5,168.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 19,045.00 | 19,286.00 | 19,431.00 | 19,781.00 | 19,881.00 | 20,091.00 |
| Deferred Tax Assets | 2,057.00 | 2,162.00 | 2,190.00 | 2,191.00 | 1,634.00 | 1,781.00 |
| Other Assets | 270.00 | 388.00 | 377.00 | 405.00 | 444.00 | 470.00 |
| Total Assets | 40,042.00 | 39,857.00 | 40,040.00 | 40,748.00 | 39,856.00 | 40,131.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 4,038.00 | 4,500.00 | 2,612.00 | 1,915.00 | 24.00 | 464.00 |
| Accounts Payable | 2,551.00 | 2,721.00 | 2,596.00 | 2,531.00 | 2,355.00 | 2,498.00 |
| Other Current Liabilities | 8,836.00 | 8,425.00 | 8,324.00 | 9,010.00 | 9,112.00 | 8,899.00 |
| Total Current Liabilities | 15,425.00 | 15,646.00 | 13,532.00 | 13,456.00 | 11,491.00 | 11,861.00 |
| Long Term Debt | 12,946.00 | 12,374.00 | 14,295.00 | 15,311.00 | 17,049.00 | 17,059.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 263.00 | 289.00 | 273.00 | 296.00 | 399.00 | 440.00 |
| Other Liabilities | 3,422.00 | 3,791.00 | 3,709.00 | 3,771.00 | 3,664.00 | 3,938.00 |
| Total Liabilities | 32,056.00 | 32,100.00 | 31,809.00 | 32,834.00 | 32,603.00 | 33,298.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 7,979.00 | 7,753.00 | 8,228.00 | 7,910.00 | 7,250.00 | 6,827.00 |
| Total Shareholders Equity | 7,979.00 | 7,753.00 | 8,228.00 | 7,910.00 | 7,250.00 | 6,827.00 |
| Accumulated Minority Interest | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 7.00 |
| Total Equity | 7,984.00 | 7,757.00 | 8,232.00 | 7,914.00 | 7,254.00 | 6,834.00 |
| Total Liabilities & Stockholders Equity | 40,040.00 | 39,857.00 | 40,041.00 | 40,748.00 | 39,857.00 | 40,132.00 |
| Book Value Per Share | 6.84 | 6.65 | 7.07 | 6.88 | 6.32 | 5.95 |
| Tangible Book Value Per Share | -9.48 | -9.90 | -9.62 | -10.32 | -11.01 | -11.56 |
| Full-Time Employees | - | - | - | 33,346 | - | 37,000 |
| Price to Book Ratio | 6.32 | 4.79 | 4.38 | 4.94 | 3.39 | 3.07 |
| Return on Assets | 1.27 | 1.77 | 3.99 | 3.52 | 1.74 | -0.39 |
| Return on Equity | 6.65 | 9.68 | 21.59 | 21.22 | 10.69 | -2.40 |
| Return on Invested Capital | 1.11 | -2.86 | 1.64 | 2.07 | 1.78 | 1.18 |
| Quick Ratio | 0.74 | 0.67 | 0.78 | 0.80 | 0.82 | 0.77 |
| Current Ratio | 0.95 | 0.88 | 1.01 | 1.04 | 1.11 | 1.06 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 238.38 | -580.29 | 369.00 | 524.19 | 474.64 | 285.10 |
| Depreciation | 235.30 | 253.32 | 239.00 | 286.87 | 279.78 | 252.06 |
| Other Funds (Non Cash) | 748.87 | 1,233.49 | 345.00 | 1,150.74 | 474.36 | 580.18 |
| Funds from Operations | 1,275.67 | 931.60 | 931.00 | 1,329.61 | 1,333.09 | 905.58 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -728.47 | -183.01 | -617.00 | 218.98 | -628.43 | -339.33 |
| Cash from Operating Activities | 547.20 | 748.58 | 314.00 | 1,548.59 | 704.65 | 566.26 |
| Capital Expenditures | -114.41 | -112.01 | -168.00 | -155.98 | -151.44 | -96.93 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | -0.57 | -1.57 | -0.16 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -748.67 | -1.03 | 0.00 | 86.37 | -14.71 | -16.11 |
| Purchase of Investments | -748.67 | -1.03 | 0.00 | 41.82 | -14.71 | -16.11 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 44.55 | 0.00 | 0.00 |
| Other Uses | 717.96 | -717.96 | 0.00 | -60.45 | 0.00 | 0.00 |
| Other Sources | 49.17 | 4.18 | 43.00 | 0.58 | 11.66 | 12.12 |
| Cash from Investing Activities | -95.95 | -826.81 | -125.00 | -130.05 | -156.07 | -101.08 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -37.63 | -0.59 | -23.00 | -27.18 | -528.05 | -0.70 |
| Change in Long Term Debt | -37.63 | -0.59 | -23.00 | -27.18 | -528.05 | -0.70 |
| Issuance of Long Term Debt | 4,862.46 | 0.00 | 0.00 | 34.43 | 88.19 | 2,314.63 |
| Reduction of Long Term Debt | -4,900.09 | -0.59 | -23.00 | -61.61 | -616.25 | -2,315.33 |
| Net Financing Active Other Cash Flow | 42.38 | -0.10 | 36.00 | 37.34 | -16.06 | -1.41 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | -5.09 | -14.09 | -1.42 |
| Cash from Financing Activities | 5.76 | -0.69 | 13.00 | 10.16 | -544.11 | -1.10 |
| Exchange Rate Effect | -26.61 | -5.56 | -17.00 | -10.14 | -7.75 | -4.83 |
| Net Change in Cash | 430.39 | -84.49 | 185.00 | 1,418.55 | -3.28 | 459.24 |
| Free Cash Flow | 432.78 | 636.58 | 146.00 | 1,392.60 | 553.21 | 469.33 |
| Price to Free Cash Flow | 18.16 | 14.10 | 13.47 | 14.82 | 11.93 | 8.80 |
Revenue breakdown
| Consolidation, Policy | 2025: 1.00M |
|---|---|
| Distribution | 2024: 1.58B 2025: 1.55B |
| License | 2024: 173.00M 2025: 678.00M |
| Product | 2024: 14.05B 2025: 14.61B |
| Product and Service, Other | 2024: 745.00M 2025: 423.00M |
| Israel | 2024: 16.54B 2025: 17.26B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 2.50% | 27.7M | 1109.6M | 5.43M |
| 2026-10-15 | 2.53% | 28.1M | 1108.2M | 5.50M |
| 2026-09-30 | 2.69% | 29.8M | 1108.2M | 5.08M |
| 2026-09-15 | 2.84% | 31.5M | 1108.2M | 5.19M |
| 2026-08-31 | 3.23% | 37.6M | 1164.5M | 5.62M |
| 2026-08-14 | 3.06% | 35.7M | 1164.5M | 5.77M |
| 2026-07-31 | 2.95% | 34.3M | 1165.1M | 5.98M |
| 2026-07-15 | 2.81% | 32.7M | 1164.5M | 6.30M |
| 2026-06-30 | 2.75% | 32.0M | 1164.5M | 6.17M |
| 2026-06-15 | 2.86% | 33.3M | 1164.5M | 6.32M |
| 2026-05-29 | 2.91% | 33.9M | 1164.5M | 6.75M |
| 2026-05-15 | 2.29% | 26.7M | 1164.5M | 6.87M |
| 2026-04-30 | 2.67% | 31.1M | 1164.5M | 7.42M |
| 2026-04-15 | 2.55% | 29.7M | 1164.5M | 7.93M |
| 2026-03-31 | 2.32% | 27.0M | 1164.5M | 9.10M |
| 2026-03-13 | 3.23% | 37.6M | 1164.5M | 9.18M |
| 2026-02-27 | 2.79% | 32.5M | 1164.5M | 9.47M |
| 2026-02-13 | 3.20% | 36.6M | 1146.7M | 10.09M |
| 2026-01-30 | 3.31% | 38.0M | 1145.0M | 11.42M |
| 2026-01-15 | 2.88% | 33.0M | 1145.0M | 11.01M |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 20.00 | 22.55 | 23.65 | 22.62 | 7.224 | 3.00 | 8.00 | 0.998 | -0.028 | 0.000 |
| call | 25.00 | 17.20 | 19.50 | 18.16 | 7.368 | 1.00 | 8.00 | 0.997 | -0.028 | 0.000 |
| call | 29.00 | 13.35 | 14.90 | 13.68 | 4.734 | 3.00 | 8.00 | 0.996 | -0.028 | 0.000 |
| call | 30.00 | 12.40 | 13.30 | 12.70 | 2.698 | 1.00 | 8.00 | 0.995 | -0.027 | 0.000 |
| call | 31.00 | 11.45 | 12.30 | 11.70 | 2.487 | 2.00 | 8.00 | 0.982 | -0.091 | 0.001 |
| call | 32.00 | 10.45 | 11.50 | 10.85 | 1.914 | 3.00 | 16.00 | 0.980 | -0.089 | 0.001 |
| call | 32.50 | 10.05 | 10.80 | 10.42 | 2.180 | 4.00 | 16.00 | 0.979 | -0.088 | 0.002 |
| call | 33.00 | 9.45 | 10.30 | 9.69 | 2.080 | 3.00 | 8.00 | 0.978 | -0.087 | 0.002 |
| call | 33.50 | 9.10 | 10.00 | 9.39 | 1.652 | 4.00 | 9.00 | 0.977 | -0.087 | 0.002 |
| call | 34.00 | 8.45 | 9.30 | 8.70 | 1.883 | 3.00 | 8.00 | 0.976 | -0.086 | 0.002 |
| call | 34.50 | 8.10 | 8.90 | 8.47 | 2.130 | 4.00 | 9.00 | 0.975 | -0.085 | 0.002 |
| call | 35.00 | 7.40 | 8.30 | 7.70 | 1.690 | 4.00 | 8.00 | 0.974 | -0.084 | 0.002 |
| call | 35.50 | 6.95 | 7.80 | 7.20 | 1.594 | 4.00 | 8.00 | 0.972 | -0.083 | 0.002 |
| call | 36.00 | 6.40 | 7.45 | 6.70 | 1.922 | 7.00 | 8.00 | 0.971 | -0.082 | 0.002 |
| call | 36.50 | 5.90 | 6.85 | 6.16 | 1.567 | 4.00 | 8.00 | 0.969 | -0.080 | 0.002 |
| call | 37.00 | 5.45 | 7.40 | 5.68 | 2.344 | 10.00 | 8.00 | 0.967 | -0.079 | 0.002 |
| call | 37.50 | 5.00 | 5.90 | 5.12 | 1.484 | 3.00 | 9.00 | 0.965 | -0.078 | 0.002 |
| call | 38.00 | 4.35 | 5.30 | 4.64 | 1.125 | 6.00 | 1.00 | 0.962 | -0.076 | 0.003 |
| call | 38.50 | 3.75 | 4.95 | 4.10 | 1.364 | 29.00 | 2.00 | 0.959 | -0.074 | 0.003 |
| call | 39.00 | 3.30 | 4.45 | 3.65 | 1.253 | 17.00 | 2.00 | 0.955 | -0.074 | 0.003 |
| call | 39.50 | 2.90 | 3.85 | 3.19 | 0.962 | 62.00 | 2.00 | 0.948 | -0.074 | 0.003 |
| call | 40.00 | 2.35 | 3.30 | 2.73 | 0.752 | 31.00 | 1.00 | 0.944 | -0.071 | 0.003 |
| call | 40.50 | 1.90 | 2.99 | 2.27 | 0.635 | 0.00 | 1.00 | 0.937 | -0.067 | 0.004 |
| call | 41.00 | 1.51 | 2.33 | 1.74 | 0.618 | 54.00 | 40.00 | 0.887 | -0.105 | 0.006 |
| call | 41.50 | 1.06 | 3.20 | 1.77 | 1.073 | 33.00 | 0.00 | 0.798 | -0.171 | 0.009 |
| call | 42.00 | 1.10 | 1.44 | 0.89 | 0.539 | 450 | 7.00 | 0.752 | -0.167 | 0.010 |
| call | 42.50 | 0.80 | 1.17 | 0.85 | 0.619 | 138 | 11.00 | 0.673 | -0.172 | 0.011 |
| call | 43.00 | 0.47 | 0.86 | 0.60 | 0.441 | 164 | 1,254 | 0.570 | -0.157 | 0.012 |
| call | 43.50 | 0.26 | 0.40 | 0.33 | 0.428 | 37.00 | 24.00 | 0.447 | -0.191 | 0.012 |
| call | 44.00 | 0.12 | 0.25 | 0.21 | 0.448 | 248 | 44.00 | 0.319 | -0.154 | 0.011 |
| call | 44.50 | 0.04 | 0.32 | 0.10 | 0.574 | 728 | 0.00 | 0.372 | -0.355 | 0.012 |
| call | 45.00 | 0.00 | 0.08 | 0.07 | 0.467 | 113 | 6.00 | 0.295 | -0.285 | 0.011 |
| call | 45.50 | 0.00 | 0.14 | 0.05 | 0.557 | 23.00 | 1.00 | 0.217 | -0.219 | 0.009 |
| call | 46.00 | 0.00 | 0.70 | 0.05 | 0.642 | 31.00 | 0.00 | 0.176 | -0.197 | 0.008 |
| call | 46.50 | 0.00 | 0.16 | 0.01 | 0.723 | 67.00 | 1.00 | 0.127 | -0.153 | 0.006 |
| call | 47.00 | 0.00 | 0.86 | 0.06 | 0.802 | 20.00 | 0.00 | 0.100 | -0.132 | 0.005 |
| call | 47.50 | 0.00 | 0.89 | 0.10 | 0.878 | 1.00 | 0.00 | 0.071 | -0.101 | 0.004 |
| call | 48.00 | 0.00 | 1.47 | 0.03 | 0.952 | 23.00 | 0.00 | 0.065 | -0.101 | 0.004 |
| call | 48.50 | 0.00 | 0.85 | 0.00 | 1.024 | 0.00 | 0.00 | 0.061 | -0.103 | 0.004 |
| call | 49.00 | 0.00 | 0.01 | 0.01 | 1.296 | 74.00 | 0.00 | 0.079 | -0.150 | 0.005 |
| call | 49.50 | 0.00 | 1.50 | 0.00 | 0.831 | 0.00 | 0.00 | 0.012 | -0.021 | 0.001 |
| call | 50.00 | 0.00 | 0.64 | 0.05 | 0.884 | 93.00 | 0.00 | 0.011 | -0.021 | 0.001 |
| call | 51.00 | 0.00 | 0.64 | 0.00 | 0.987 | 0.00 | 0.00 | 0.010 | -0.022 | 0.001 |
| call | 52.00 | 0.00 | 1.69 | 0.00 | 1.087 | 0.00 | 0.00 | 0.009 | -0.022 | 0.001 |
| put | 20.00 | 0.00 | 2.12 | 0.00 | 4.080 | 0.00 | 0.00 | -0.002 | -0.026 | 0.000 |
| put | 25.00 | 0.00 | 0.22 | 0.00 | 2.969 | 0.00 | 0.00 | -0.003 | -0.025 | 0.000 |
| put | 29.00 | 0.00 | 2.12 | 0.00 | 2.222 | 0.00 | 0.00 | -0.004 | -0.024 | 0.000 |
| put | 30.00 | 0.00 | 0.01 | 0.00 | 3.691 | 0.00 | 0.00 | -0.078 | -0.419 | 0.005 |
| put | 31.00 | 0.00 | 2.12 | 0.00 | 2.335 | 0.00 | 0.00 | -0.018 | -0.087 | 0.001 |
| put | 32.00 | 0.00 | 0.87 | 0.02 | 2.140 | 1.00 | 0.00 | -0.020 | -0.086 | 0.001 |
| put | 32.50 | 0.00 | 2.12 | 0.00 | 2.044 | 0.00 | 0.00 | -0.021 | -0.085 | 0.002 |
| put | 33.00 | 0.00 | 1.87 | 0.04 | 1.950 | 13.00 | 0.00 | -0.022 | -0.084 | 0.002 |
| put | 33.50 | 0.00 | 2.12 | 0.00 | 1.856 | 0.00 | 0.00 | -0.023 | -0.083 | 0.002 |
| put | 34.00 | 0.00 | 0.91 | 0.00 | 1.763 | 0.00 | 0.00 | -0.024 | -0.082 | 0.002 |
| put | 34.50 | 0.00 | 2.12 | 0.00 | 1.671 | 0.00 | 0.00 | -0.025 | -0.081 | 0.002 |
| put | 35.00 | 0.00 | 0.47 | 0.11 | 1.580 | 219 | 0.00 | -0.026 | -0.080 | 0.002 |
| put | 35.50 | 0.00 | 1.52 | 0.06 | 1.490 | 41.00 | 0.00 | -0.028 | -0.079 | 0.002 |
| put | 36.00 | 0.00 | 1.55 | 0.10 | 1.400 | 87.00 | 0.00 | -0.029 | -0.078 | 0.002 |
| put | 36.50 | 0.00 | 2.13 | 0.10 | 1.311 | 6.00 | 0.00 | -0.031 | -0.076 | 0.002 |
| put | 37.00 | 0.00 | 1.07 | 0.01 | 1.223 | 49.00 | 0.00 | -0.033 | -0.075 | 0.002 |
| put | 37.50 | 0.00 | 1.96 | 0.11 | 1.134 | 1.00 | 0.00 | -0.035 | -0.074 | 0.002 |
| put | 38.00 | 0.00 | 2.13 | 0.12 | 1.046 | 8.00 | 0.00 | -0.038 | -0.072 | 0.003 |
| put | 38.50 | 0.00 | 1.27 | 0.24 | 0.958 | 1.00 | 0.00 | -0.041 | -0.070 | 0.003 |
| put | 39.00 | 0.00 | 0.35 | 0.13 | 0.871 | 200 | 0.00 | -0.045 | -0.070 | 0.003 |
| put | 39.50 | 0.00 | 0.58 | 0.07 | 0.782 | 6.00 | 0.00 | -0.052 | -0.070 | 0.003 |
| put | 40.00 | 0.00 | 0.24 | 0.02 | 0.694 | 198 | 17.00 | -0.056 | -0.066 | 0.003 |
| put | 40.50 | 0.00 | 0.05 | 0.05 | 0.605 | 9.00 | 14.00 | -0.063 | -0.063 | 0.004 |
| put | 41.00 | 0.00 | 0.11 | 0.32 | 0.632 | 157 | 0.00 | -0.113 | -0.100 | 0.006 |
| put | 41.50 | 0.05 | 0.13 | 0.45 | 0.556 | 317 | 0.00 | -0.202 | -0.166 | 0.009 |
| put | 42.00 | 0.00 | 0.37 | 0.15 | 0.663 | 91.00 | 24.00 | -0.248 | -0.162 | 0.010 |
| put | 42.50 | 0.20 | 0.33 | 0.39 | 0.518 | 215 | 6.00 | -0.327 | -0.167 | 0.011 |
| put | 43.00 | 0.36 | 0.50 | 0.45 | 0.498 | 10.00 | 60.00 | -0.430 | -0.153 | 0.012 |
| put | 43.50 | 0.45 | 1.04 | 1.04 | 0.733 | 73.00 | 0.00 | -0.553 | -0.186 | 0.012 |
| put | 44.00 | 0.78 | 1.19 | 3.30 | 0.602 | 1.00 | 0.00 | -0.681 | -0.149 | 0.011 |
| put | 44.50 | 1.32 | 3.30 | 0.00 | 2.111 | 0.00 | 0.00 | -0.628 | -0.350 | 0.012 |
| put | 45.00 | 1.63 | 3.50 | 0.00 | 2.019 | 0.00 | 0.00 | -0.719 | -0.257 | 0.010 |
| put | 45.50 | 2.10 | 3.75 | 0.00 | 1.955 | 0.00 | 0.00 | -0.783 | -0.214 | 0.009 |
| put | 46.00 | 2.63 | 4.30 | 0.00 | 2.136 | 0.00 | 0.00 | -0.824 | -0.192 | 0.008 |
| put | 46.50 | 3.20 | 4.50 | 4.01 | 2.002 | 0.00 | 1.00 | -0.873 | -0.148 | 0.006 |
| put | 47.00 | 3.65 | 5.20 | 0.00 | 2.307 | 0.00 | 0.00 | -0.900 | -0.127 | 0.005 |
| put | 47.50 | 4.15 | 5.40 | 4.93 | 2.151 | 1.00 | 3.00 | -0.929 | -0.095 | 0.004 |
| put | 48.00 | 4.70 | 6.10 | 5.57 | 2.454 | 0.00 | 2.00 | -0.935 | -0.095 | 0.004 |
| put | 48.50 | 5.15 | 6.60 | 6.07 | 2.614 | 2.00 | 4.00 | -0.939 | -0.098 | 0.004 |
| put | 49.00 | 5.55 | 7.15 | 6.50 | 2.725 | 6.00 | 4.00 | -0.988 | -0.015 | 0.001 |
| put | 49.50 | 6.15 | 7.70 | 7.49 | 2.880 | 5.00 | 0.00 | -0.988 | -0.016 | 0.001 |
| put | 50.00 | 6.65 | 8.15 | 8.00 | 2.937 | 4.00 | 0.00 | -0.989 | -0.016 | 0.001 |
| put | 51.00 | 7.65 | 9.15 | 8.93 | 3.138 | 2.00 | 0.00 | -0.990 | -0.016 | 0.001 |
| put | 52.00 | 8.55 | 10.15 | 0.00 | 3.330 | 0.00 | 0.00 | -0.991 | -0.017 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-10 | SCHEDULE 13G/A | SEC | ||
| 2026-11-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-05 | SEC |
| 2026-11-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-04 | SEC |
| 2026-11-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-04 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-03 | 8-K | Current report | 2026-11-03 | SEC |
| 2026-11-03 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-02 | SCHEDULE 13G/A | SEC | ||
| 2026-10-29 | 8-K | Current report | 2026-10-27 | SEC |
| 2026-10-08 | 3 | Initial statement of beneficial ownership of securities | 2026-09-29 | SEC |
| 2026-09-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-18 | SEC |
| 2026-09-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-19 | SEC |
| 2026-09-21 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-16 | 8-K | Current report | 2026-09-16 | SEC |
| 2026-09-14 | 8-K | Current report | 2026-09-14 | SEC |
| 2026-09-14 | 8-A12B/A | SEC | ||
| 2026-09-14 | 25-NSE | SEC | ||
| 2026-09-11 | 424B5 | SEC | ||
| 2026-09-11 | 8-K | Current report | 2026-09-09 | SEC |
| 2026-09-10 | FWP | Filing under Securities Act Rule 163/433 of free writing prospectuses. | SEC | |
| 2026-09-10 | FWP | Filing under Securities Act Rule 163/433 of free writing prospectuses. | SEC | |
| 2026-09-08 | 424B5 | SEC | ||
| 2026-09-03 | 8-K | Current report | 2026-09-03 | SEC |
| 2026-09-03 | 8-K | Current report | 2026-08-31 | SEC |
| 2026-08-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-17 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 3.02M | 2 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 14.64M | 2 |
| 2026-08 | 0 | 0 | 2.39M | 6 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 4.70M | 4 |
| 2026-05 | 0 | 0 | 13.43M | 5 |
| 2026-04 | 0 | 0 | 750.62K | 1 |
| 2026-03 | 0 | 0 | 30.29M | 17 |
| 2026-02 | 0 | 0 | 26.96M | 2 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 12.25M | 4 |
| 2025-11 | 0 | 0 | 7.88M | 5 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 5.49% |
| Harel Insurance Investments & Financial Services Ltd. | 4.13% |
| Phoenix Financial Ltd. | 3.69% |
| WCM INVESTMENT MANAGEMENT, LLC | 3.55% |
| Clal Insurance Enterprises Holdings Ltd | 3.49% |
| MENORA MIVTACHIM HOLDINGS LTD. | 3.42% |
| Migdal Insurance & Financial Holdings Ltd. | 3.38% |
| NORGES BANK | 2.77% |
| FMR LLC | 2.60% |
| Lingotto Investment Management LLP | 1.73% |
Funds
| Fund | % owned |
|---|---|
| Bond Fund | 2.24% |
| Baird Core Plus Bond Fund | 1.79% |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | 1.47% |
| WCM Focused International Growth Fund | 1.14% |
| VANGUARD DEVELOPED MARKETS INDEX FUND | 0.97% |
| New Economy Fund | 0.82% |
| Investment Grade Bond Fund | 0.56% |
| Baird Aggregate Bond Fund | 0.51% |
| Short Duration Bond Fund | 0.49% |
| Strategic Advisers Fidelity International Fund | 0.40% |
OakChart. TEVA. Cached 15 minutes.